Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Models

Models

Bernardo Innocenti, Professor

ULB
" The aim is to develop and validate a numerical model of a human lung to predict its degeneration over time, in order to provide better knowledge and further info for decision-making to the clinician, addressing both the treatment and the follow-up of the patients after the pathology. "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Caroline Huart, MD, PhD - Bernard Hanseeuw, MD, PhD - Valérie Hox, MD, PhD - Pascal Kienlen-Campard, PhD- Vincent Van Pesch, MD, PhD

UCLouvain and Cliniques universitaires Saint-Luc - FNRS
" Anosmia has been reported to be a major symptom of COVID-19. Since high viral loads are found in the nasal cavity of patients and since single-cell analyses found that olfactory sustentacular and stem cells highly express ACE2 and TMPRSS2, it is suspected that cells of the olfactory neuroepithelium are a preferred target of the virus. Some COVID-19 patients present with neurological symptoms. Interestingly, it has been reported that the former SARS-CoV, can ascend intracranially, possibly via the olfactory nerves. Since olfactory receptor neurons form a direct connection between the nasal cavity and the brain, we hypothesize that these cells act as a gateway towards the brain in some patients. The main aims of the projects are (1) to investigate the pathophysiology of COVID-related olfactory dysfunction and (2) to investigate whether olfactory receptor neurons could be the entry site of SARS-CoV2 to the brain. "
Funding...

Charles Nicaise, Professor

UNamur
" In vitro studies will investigate the abilities of SARS-Cov-2 to enter various types of human neurons (cell lines and iPS-derived) and possible axoplasmic transport. In the meantime, analysis of post-mortem CNS and PNS samples from COVID patients would strengthen the hypothesis of SARS-Cov-2 neuro-tropism. "
Funding: CUR-FNRS (pending)
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Charles Pilette, Professor

UCLouvain, St-Luc
" We aim to characterize the reprogramming of structural cells of the lungs that are direct targets of the SARS-CoV-2, namely type 2 alveolar epithelial cells and endothelial cells, as well as their potential role in the induction of the (hyper)inflammatory phase of the disease leading to acute lung injury. The skills of our laboratory in lung and mucosal immunology research that are relevant to this field are (1) access to precious human lung tissue (e.g. from SARS-CoV-2 patients), (2) multiplex immunofluorescence staining and isolation of structural cells (e.g. alveolar epithelial cells, endothelial cells) from the human lung, as well as (3) their characterization using cell culture-based readouts and (in collab. with the UCL-CTMA) genetic sequencing. "
Funding: FNRS CUR, application submitted on 01-05-20.
Publication References: 1. Gohy ST, Hupin C, Fregimilicka C, Detry BR, Bouzin C, Gaide Chevronay H, Lecocq M, Weynand B, Ladjemi MZ, Pierreux CE, Birembaut P...

Daniel Desmecht, Professor - Mutien Garigliany, Professor

FARAH - ULiège 
" We are describing the evolution of the respiratory function after infection using whole-body plethysmography in a hamster model of SARS-CoV-2 pneumonia. Although the tropism of the virus for the upper respiratory tract is well documented, little is known about the pathophysiological mechanisms involved in the impairment of the respiratory function and the development of acute respiratory distress syndrome (ARDS) in some patients. There is a critical need for the development of noninvasive evaluation tools of the respiratory function over the disease course in order to develop therapeutic strategies aiming at specifically improving this function. Plethysmography is a noninvasive method allowing the quantitative evaluation of the lung volume and function. The selected plethysmographic parameters will allow a noninvasive monitoring of the lung function and lesions in the hamster model, permitting the screening of therapeutic molecules aiming at alleviating the...

Daniel Desmecht, Professor - Mutien Garigliany, Professor

FARAH - ULiège 
" We recently showed that domestic cats can be spontaneously infected by SARS-CoV-2 and develop transient, yet severe, pneumonia. Similar reports in other countries confirmed the susceptibility of cats, ferrets, lions and tigers to the infection. Dogs can get infected but, apparenlty, subclinically. Beside the importance of these findings for veterinarians and animal health, a series of domestic or wild animal species might constitute a reservoir of SARS-CoV-2 and dramatically complicate the "uncontainment" process. Domestic cats, minks, ferrets, hamsters, dogs, tigers and lions were all shown to be naturally or (for some species) experimentally susceptible to SARS-CoV-2 infection. In addition, cats, minks, ferrets and hamsters were shown to be able to efficiently transmit the virus to in-contact animals. Little is known about the actual host range of the virus. It is critically needed to determine which domestic, peri-domestic (especially rodents) and wild animals can...

Didier Serteyn, Professor - Justine Ceusters, CSO RevaTis - Charlotte Sandersen, Professor

ULiège and RevaTis SA (Spin Off)
" The project aims to assess the effects of muscle derived stem cells on a preclinical model of acute respiratory distress syndrome induced by a perfusion of endotoxins. We focused on the modulation of neutrophil excessive activation. RevaTis developped a GMP production of muscle derived Mesenchymal Stem Cells and is authorized to produce clinical batches. The IPCLab (Liege University) developed an ARDS model in pigs. We aim to demonstrate a reduction of the ARDS severity, a reduction of the cytokines storm and a modulation of the excessive activation of neutrophils observed in ARDS. "
Funding: Research grants from Ulg (POC) and FNRS (CURE) are pending. RevaTis supplies muscle derived Stem Cells for R&D projects
Publication References: Sci Rep. 2017 Apr 6;7(1):696. doi: 10.1038/s41598-017-00803-7. From skeletal muscle to stem cells: an innovative and minimally-invasive process for multiple species. Ceusters J, Lejeune JP, Sandersen C, Niesten A...

Gregory Ponthiere, Professor

UCLouvain
" This research project aims at studying the conditions under which the modern welfare state could build a kind of epidemics insurance, while paying a particular attention to the issue of fairness. The global objective of saving lives may be associated to policies that have undesirable distributive effects, against ideals of social justice. The project aims at finding ways to make mass prevention and equity compatible. "
Funding: This project will be part of my research load at UCLouvain, within the Hoover Chair in Economic ans Social Ethics.
Publication References: Fleurbaey, M., Ponthiere, G. (2013). Prevention against Equality ? Journal of Public Economics. Fleurbaey, M., Leroux, ML, Ponthiere, G. (2014). Compensating the dead. Journal of Mathematical Economics. Fleurbaey, M., Leroux, ML., Pestieau, P., Ponthiere G. (2016). Fair retirement under risk lifetime. International Economic Review. Leroux, ML., Ponthiere, G. (2018). Working time regulations, unequal lifetime and...

Jennifer Denis, PhD in psychology research and teaching associate

UMONS
" The 2019 coronavirus disease (COVID-19) pandemic is a public health emergency of international concern. Authorities and population are facing a global health crisis which pose a challenge to adapt quickly and effectively. The aim of this preliminary study was to survey the general public in Belgium to better understand their levels of psychological impact, anxiety and stress during the initial stage of containment. The data also explored tips and tricks immediately adopt by the population to manage containment. From 20 March to 28 March 2020, we conducted an online survey using snowball sampling techniques on social network. The online survey collected information on demographic data, stress level in the past 7 days, knowledge and concerns about COVID-19 and the impact of using technologies for taking information and stay connected to others, precautionary measures (tips and tricks) during the beginning of containment, and additional information required with respect to...

Jurga Marcin, PhD

EXO Biologics
" EXO Biologics plans to extend its research and development program towards the COVID-19 crisis by using its unique and disruptive technology based on Extracellular Vesicles. These nanometer size particles are gaining momentum in the scientific community as potential alternatives to stem cell and biologic drugs therapies in the fields of immunology, neurology, oncology, cardiology, gastroenterology among others. EXO Biologics has 12 years of experience in cell-based regenerative medicine and 8 years of experience in Extracellular Vesicles. Our advancements in research will play an important role for our company mission to provide affordable and accessible therapies to patients with unmet medical needs. "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Marianne Rooman, FNRS Research Director - Fabrizio Pucci, FNRS Postdoctoral Researcher

ULB - FNRS
" Computational analysis of the impact of SARS-CoV-2 on the renin-angiotensin system. "
Funding: FNRS
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it.

Mutien Garigliany, Professor - Daniel Desmecht, Professor

ULiège 
" There is a critical need for therapeutic solutions against SARS-CoV-2. Before implementing innovative treatments in human medicine, a first screening of the antiviral or immunomodulatory activity should be performed by in vitro and in vivo methods. To this aim, we developed in vitro (cell culture) and in vivo (hamsters and mice) models of SARS-CoV-2 infection. We developed an in vitro (cell culture) and in vivo (hamsters and mice) to screen antiviral or immunomodulatory molecules, in partnership with colleagues from the ULiège hospital and the GIGA research center. We also validate the inactivation protocols to facilitate the diagnostic workflow, in partnership with the Federal task force. "
Funding: Currently no funding. We applied to the "Crédits urgents de recherche" call.
Contact: Mutien Garigliany, DVM, PhD, Dipl. ECVP Professor Department of Pathology Faculty of Veterinary Medicine Centre for Fundamental and Applied Research for Animals & Health (FARAH) Liège...

Mutien Garigliany, Professor - Daniel Desmecht, Professor

FARAH - ULiège 
" As of today, one of the most promising therapeutic solutions against COVID-19 is the use of convalescent plasma. A subset of the antibodies present in this plasma are able to bind the surface proteins of the virus, chiefly the Spike (attachment) protein, and to neutralize the ability of viral particles to infect permissive cells. Upon request of the Red Cross and ULiège CHU hospital, we developed seroneutralization assays to determine the titers in neutralizing antibodies of convalescent plasma. In collaboration with KU Leuven (Rega) and ITM Antwerp, we just completed an interlaboratory ring test. We screen convalescent plasmas on a routine basis for the Croix Rouge and Rode Kruis. Only plasmas with a titer in neutralizing antibodies above the cut-off value will be used therapeutically. The scarcity of the scientific literature on the subject (only a few studies on the therapeutic use of convalescent plasmas are currently available) make it difficult to fix a cut-off...

Pierre Morsomme, Professor - Henri-François Renard, Professor

UCLouvain - UNamur
" One of the key determining factors in viral infection is the entry of the virus into the host cells. Different CoVs including MHV, SARS-CoV and MERS-CoV have been consistently demonstrated to engage the endocytic pathway as the main mechanism for viral entry into a variety types of host cells. At present, the entry mechanisms and the implication of the endocytic pathway of the new emerging SARS-CoV-2 have not been reported directly. It is known that SARS-CoV-2 utilizes the same receptor of SARS-CoV, which is angiotensin converting enzyme II (ACE2) for viral entry into the host cells. Since SARS-CoV-2 also binds to the same ACE2 receptor as SARS-CoV it is highly possible that this new CoV utilizes the same endocytic pathway for entry into the host cells. Besides, a recent report suggests that SARS-CoV-2 invaded host cells via another route of CD147-spike protein. Our lab is studying the endocytosis mechanism of several plasma membrane receptors previously...

Saïd Mahmoudi, Professor - Thierry Dutoit, Full Professor - Sidi Ahmed Mahmoudi, Professor- Xavier Lessage, Eng - Sohaib Laraba, Eng - Omar Seddati, Phd - Mohammed Amin Belarbi, Eng - Olivier Debauche, Eng

UMONS - Faculty of Engineering - ILIA and ISIA Departments
" This study allows an early Covid-19 diagnosis by using AI and explainable based classification and detection methods applied to CT and X-ray datasets. Many datasets form several hospitals in Belgium are used. The goal of the project is to use AI based methods to identify Covid-19 patients. Explainable AI methods are used to provide efficient interpretation and visualization tools for the classification and detection results obtained. The second goal of this project is to create a benchmark dataset composed of chest CT and X-ray database related to Covid-19 disease. To this aim, a semi-automatic annotation tool is developed in order to allow fast image annotation by radiologists. - Explainable artificial intelligence applied to Covid-19 detection based on CT and X-ray images. - Annotation tool development to build a benchmark database. "
Funding: University of Mons - Faculty of Engineering
Publication References: ...

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19